Exercise and omega-3 polyunsaturated fatty acid supplementation for the treatment of hepatic steatosis in hyperphagic OLETF rats

Journal of Nutrition and Metabolism

Volumn 2012, Issue , 2012, Pages

  Borengasser, Sarah J ^a,b   Rector, R Scott ^a,b,c   Uptergrove, Grace M ^a   Morris, E Matthew ^a,b   Perfield II, James W ^a,b   Booth, Frank W ^a,b,d   Fritsche, Kevin L ^b   Ibdah, Jamal A ^a,c   Thyfault, John P ^a,b,c  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; RATTUS;

EID: 84863313432     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2012/268680     Document Type: Article

References (42)

1. Clark J. M., Brancati F. L., Diehl A. M., Nonalcoholic fatty liver disease. Gastroenterology 2002 122 6 1649 1657 2-s2.0-0036090972 (Pubitemid 34533559)
2. Rector R. S., Thyfault J. P., Wei Y., Ibdah J. A., Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World Journal of Gastroenterology 2008 14 2 185 192 2-s2.0-39849099669 10.3748/wjg.14.185 (Pubitemid 351314297)
3. Aygun C., Kocaman O., Sahin T., Uraz S., Eminler A. T., Celebi A., Senturk O., Hulagu S., Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Digestive Diseases and Sciences 2008 53 5 1352 1357 2-s2.0-41949124892 10.1007/s10620-007-9998-7 (Pubitemid 351514649)
4. Rubinstein E., Lavine J. E., Schwimmer J. B., Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Seminars in Liver Disease 2008 28 4 380 385 2-s2.0-56649107955 10.1055/s-0028-1091982
5. Targher G., Bertolini L., Padovani R., Rodella S., Zoppini G., Zenari L., Cigolini M., Falezza G., Arcaro G., Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006 29 6 1325 1330 2-s2.0-33746421488 10.2337/dc06-0135 (Pubitemid 44125930)
6. Schindhelm R. K., Diamant M., Dekker J. M., Tushuizen M. E., Teerlink T., Heine R. J., Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes, Metabolism Research and Reviews 2006 22 6 437 443 2-s2.0-33750454286 10.1002/dmrr.666 (Pubitemid 44774047)
7. Dunn W., Xu R., Wingard D. L., Rogers C., Angulo P., Younossi Z. M., Schwimmer J. B., Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. American Journal of Gastroenterology 2008 103 9 2263 2271 2-s2.0-50649094716 10.1111/j.1572-0241.2008.02034.x
8. Ong J. P., Pitts A., Younossi Z. M., Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. Journal of Hepatology 2008 49 4 608 612 2-s2.0-50549084740 10.1016/j.jhep.2008.06.018
9. Rector R. S., Thyfault J. P., Morris R. T., Laye M. J., Borengasser S. J., Booth F. W., Ibdah J. A., Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008 294 3 G619 G626 2-s2.0-41549166521 10.1152/ajpgi.00428.2007 (Pubitemid 351468778)
10. Rector R. S., Thyfault J. P., Uptergrove G. M., Morris E. M., Naples S. P., Borengasser S. J., Mikus C. R., Laye M. J., Laughlin M. H., Booth F. W., Ibdah J. A., Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. Journal of Hepatology 2010 52 5 727 736 2-s2.0-77951632831 10.1016/j.jhep.2009.11.030
11. Moran T. H., Bi S., Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects. Developmental Psychobiology 2006 48 5 360 367 2-s2.0-33746268381 10.1002/dev.20149 (Pubitemid 44090281)
12. Rector S. R., Thyfault J. P., Laye M. J., Morris T. R., Borengasser S. J., Uptergrove G. M., Chakravarthy M. V., Booth F. W., Ibdah J. A., Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Journal of Physiology 2008 586 17 4241 4249 2-s2.0-51749108218 10.1113/jphysiol.2008.156745
13. He Y., Zhang H., Fu F. H., The effects of swimming exercise on high-fat-diet-induced steatohepatitis. Journal of Sports Medicine and Physical Fitness 2008 48 2 259 265 2-s2.0-46349104762
14. Sene-Fiorese M., Duarte F. O., Scarmagnani F. R. R., Cheik N. C., Manzoni M. S. J., Nonaka K. O., Rossi E. A., De Oliveira Duarte A. C. G., Dâmaso A. R., Efficiency of intermittent exercise on adiposity and fatty liver in rats fed with high-fat diet. Obesity 2008 16 10 2217 2222 2-s2.0-53849083414 10.1038/oby.2008.339
15. Botolin D., Wang Y., Christian B., Jump D. B., Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways. Journal of Lipid Research 2006 47 1 181 192 2-s2.0-30844437681 10.1194/jlr.M500365-JLR200 (Pubitemid 43107461)
16. Kim H. J., Takahashi M., Ezaki O., Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. Journal of Biological Chemistry 1999 274 36 25892 25898 2-s2.0-0033520484 10.1074/jbc.274.36.25892 (Pubitemid 29418625)
17. Pawar A., Jump D. B., Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor α activity in rat primary hepatoctes. Journal of Biological Chemistry 2003 278 38 35931 35939 2-s2.0-0141592581 10.1074/jbc.M306238200 (Pubitemid 37139911)
18. Qin X., Xie X., Fan Y., Tian J., Guan Y., Wang X., Zhu Y., Wang N., Peroxisome proliferator-activated receptor- δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. Hepatology 2008 48 2 432 441 2-s2.0-49649129066 10.1002/hep.22334
19. Sekiya M., Yahagi N., Matsuzaka T., Najima Y., Nakakuki M., Nagai R., Ishibashi S., Osuga J. I., Yamada N., Shimano H., Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003 38 6 1529 1539 2-s2.0-0345448923 10.1016/j.hep.2003.09.028 (Pubitemid 37466979)
20. Svegliati-Baroni G., Candelaresi C., Saccomanno S., Ferretti G., Bachetti T., Marzioni M., De Minicis S., Nobili L., Salzano R., Omenetti A., Pacetti D., Sigmund S., Benedetti A., Casini A., A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor- α and n-3 polyunsaturated fatty acid treatment on liver injury. American Journal of Pathology 2006 169 3 846 860 2-s2.0-33748794808 10.2353/ajpath.2006.050953 (Pubitemid 44411952)
21. Tanaka N., Sano K., Horiuchi A., Tanaka E., Kiyosawa K., Aoyama T., Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. Journal of Clinical Gastroenterology 2008 42 4 413 418 2-s2.0-41349102802 10.1097/MCG.0b013e31815591aa (Pubitemid 351450629)
22. Yahagi N., Shimano H., Hasty A. H., Amemiya-Kudo M., Okazaki H., Tamura Y., Iizuka Y., Shionoiri F., Ohashi K., Osuga J. I., Harada K., Gotoda T., Nagai R., Ishibashi S., Yamada N., A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. Journal of Biological Chemistry 1999 274 50 35840 35844 2-s2.0-0033544869 10.1074/jbc.274.50.35840 (Pubitemid 129512889)
23. Capanni M., Calella F., Biagini M. R., Genise S., Raimondi L., Bedogni G., Svegliati-Baroni G., Sofi F., Milani S., Abbate R., Surrenti C., Casini A., Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Alimentary Pharmacology and Therapeutics 2006 23 8 1143 1151 2-s2.0-33646882162 10.1111/j.1365-2036.2006.02885.x (Pubitemid 43779354)
24. Spadaro L., Magliocco O., Spampinato D., Piro S., Oliveri C., Alagona C., Papa G., Rabuazzo A. M., Purrello F., Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Digestive and Liver Disease 2008 40 3 194 199 2-s2.0-38749115791 10.1016/j.dld.2007.10.003 (Pubitemid 351181793)
25. Shirouchi B., Nagao K., Inoue N., Ohkubo T., Hibino H., Yanagita T., Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. Journal of Agricultural and Food Chemistry 2007 55 17 7170 7176 2-s2.0-34548295721 10.1021/jf071225x (Pubitemid 47338962)
26. Rector R. S., Uptergrove G. M., Borengasser S. J., Mikus C. R., Morris E. M., Naples S. P., Laye M. J., Laughlin M. H., Booth F. W., Ibdah J. A., Thyfault J. P., thyfaultj@missouri.edu Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hyperphagic OLETF rats. American Journal of Physiology, Endocrinology and Metabolism 2010 298 6 E1179 E1187 10.1152/ajpendo.00703.2009
27. Laye M. J., Scott Rector R., Borengasser S. J., Naples S. P., Uptergrove G. M., Ibdah J. A., Booth F. W., Thyfault J. P., Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue. Journal of Applied Physiology 2008 106 1 161 168 2-s2.0-58649114097 10.1152/japplphysiol.91186.2008
28. Folch J., Lees M., Stanley G. H. S., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957 226 1 497 509 2-s2.0-70449158340
29. Wei Y., Clark S. E., Morris E. M., Thyfault J. P., Uptergrove G. M. E., Whaley-Connell A. T., Ferrario C. M., Sowers J. R., Ibdah J. A., Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats. Journal of Hepatology 2008 49 3 417 428 2-s2.0-48449097273 10.1016/j.jhep.2008.03.018
30. Jong E. Y., Kyung M. C., Sei H. B., Kyoung O. K., Hyoung J. L., Ki H. P., Jin Y. K., Park J. J., Jae S. K., Bak Y. T., Kwan S. B., Chang H. L., Reduced expression of peroxisome proliferator-activated receptor- α may have an important role in the development of non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2004 19 7 799 804 2-s2.0-3242795074 10.1111/j.1440-1746.2004.03349.x (Pubitemid 38981403)
31. Madsen L., Garras A., Asins G., Serra D., Hegardt F. G., Berge R. K., Mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion and peroxisome proliferation. Biochemical Pharmacology 1999 57 9 1011 1019 2-s2.0-0032946594 10.1016/S0006-2952(99)00004-0 (Pubitemid 29168549)
32. Ukropec J., Klimě I., Gašperíková D., Demcáková E., Drevon C. A., Reseland J. E., Šebö ková E., ueensebo@savba.savba.sk An increase in peroxisomal fatty acid oxidation is not sufficient to prevent tissue lipid accumulation in hHTg rats. Annals of the New York Academy of Sciences 2002 967 71 79 (Pubitemid 34721895)
33. Wanders R. J. A., Vreken P., Ferdinandusse S., Jansen G. A., Waterham H. R., Van Roermund C. W. T., Van Grunsven E. G., Peroxisomal fatty acid α-and β -oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochemical Society Transactions 2001 29 2 250 267 2-s2.0-0034956080 10.1042/0300-5127:0290250 (Pubitemid 32587514)
34. Morris R. T., Laye M. J., Lees S. J., Rector R. S., Thyfault J. P., Booth F. W., Exercise-induced attenuation of obesity, hyperinsulinemia, and skeletal muscle lipid peroxidation in the OLETF rat. Journal of Applied Physiology 2008 104 3 708 715 2-s2.0-41549137762 10.1152/japplphysiol.01034.2007 (Pubitemid 351468799)
35. Levy J. R., Clore J. N., Stevens W., Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in fischer 344 rats. Hepatology 2004 39 3 608 616 2-s2.0-1542410333 10.1002/hep.20093 (Pubitemid 38337640)
36. Nakatani T., Kim H. J., Kaburagi Y., Yasuda K., Ezaki O., A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. Journal of Lipid Research 2003 44 2 369 379 2-s2.0-0142091723 10.1194/jlr.M200289-JLR200 (Pubitemid 37287780)
37. Xu J., Cho H., O'Malley S., Park J. H. Y., Clarke S. D., Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and -2 in three distinct stages and by different mechanisms. Journal of Nutrition 2002 132 11 3333 3339 2-s2.0-0036846040 (Pubitemid 35304240)
38. González-Périz A., Planaguma A., Gronert K., Miquel R., López-Parra M., Titos E., Horrillo R., Ferré N., Deulofeu R., Arroyo V., Rodés J., Clària J., jclaria@clinic.ub.es Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB Journal 2006 20 14 2537 2539 10.1096/fj.06-6250fje (Pubitemid 44953772)
39. Fritsche K., Fatty acids as modulators of the immune response. Annual Review of Nutrition 2006 26 45 73 2-s2.0-33750110432 10.1146/annurev.nutr.25. 050304.092610
40. Fritsche K., Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents. Lipids 2007 42 11 961 979 2-s2.0-36249005022 10.1007/s11745-007-3106-9 (Pubitemid 350127311)
41. Nakatani T., Katsumata A., Miura S., Kamei Y., Ezaki O., Effects of fish oil feeding and fasting on LXR α /RXR α binding to LXRE in the SREBP-1c promoter in mouse liver. Biochimica et Biophysica Acta 2005 1736 1 77 86 2-s2.0-23944461282 10.1016/j.bbalip.2005.07.003 (Pubitemid 41208262)
42. Vega G. L., Chandalia M., Szczepaniak L. S., Grundy S. M., Effects of N-3 fatty acids on hepatic triglyceride content in humans. Journal of Investigative Medicine 2008 56 5 780 785 2-s2.0-49149084590